Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution

Aims: Inhalation of air pollution small particle matter (PM) is a leading cause of cardiovascular (CV) disease. Exposure to PMs causes endothelial cell (EC) dysfunction as evidenced by nitric oxide (NO) synthase uncoupling, vasoconstriction and inflammation. Eicosapentaenoic acid (EPA) has been show...

Full description

Bibliographic Details
Main Authors: Samuel C.R. Sherratt, Peter Libby, Hazem Dawoud, Deepak L. Bhatt, Tadeusz Malinski, R. Preston Mason
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223004171
_version_ 1797837149220896768
author Samuel C.R. Sherratt
Peter Libby
Hazem Dawoud
Deepak L. Bhatt
Tadeusz Malinski
R. Preston Mason
author_facet Samuel C.R. Sherratt
Peter Libby
Hazem Dawoud
Deepak L. Bhatt
Tadeusz Malinski
R. Preston Mason
author_sort Samuel C.R. Sherratt
collection DOAJ
description Aims: Inhalation of air pollution small particle matter (PM) is a leading cause of cardiovascular (CV) disease. Exposure to PMs causes endothelial cell (EC) dysfunction as evidenced by nitric oxide (NO) synthase uncoupling, vasoconstriction and inflammation. Eicosapentaenoic acid (EPA) has been shown to mitigate PM-induced adverse cardiac changes in patients receiving omega-3 fatty acid supplementation. We set out to determine the pro-inflammatory effects of multiple PMs (urban and fine) on pulmonary EC NO bioavailability and protein expression, and whether EPA restores EC function under these conditions. Methods and results: We pretreated pulmonary ECs with EPA and then exposed them to urban or fine air pollution PMs. LC/MS-based proteomic analysis to assess relative expression levels. Expression of adhesion molecules was measured by immunochemistry. The ratio of NO to peroxynitrite (ONOO–) release, an indication of eNOS coupling, was measured using porphyrinic nanosensors following calcium stimulation. Urban/fine PMs also modulated 9/12 and 13/36 proteins, respectively, linked to platelet and neutrophil degranulation pathways and caused > 50% (p < 0.001) decrease in the stimulated NO/ONOO– release ratio. EPA treatment altered expression of proteins involved in these inflammatory pathways, including a decrease in peroxiredoxin-5 and an increase in superoxide dismutase-1. EPA also increased expression of heme oxygenase-1 (HMOX1), a cytoprotective protein, by 2.1-fold (p = 0.024). EPA reduced elevations in sICAM-1 levels by 22% (p < 0.01) and improved the NO/ONOO– release ratio by > 35% (p < 0.05). Conclusion: These cellular changes may contribute to anti-inflammatory, cytoprotective and lipid changes associated with EPA treatment during air pollution exposure.
first_indexed 2024-04-09T15:20:07Z
format Article
id doaj.art-24031662b6d14eeead7efd230a03d49a
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-09T15:20:07Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-24031662b6d14eeead7efd230a03d49a2023-04-29T14:46:06ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-06-01162114629Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollutionSamuel C.R. Sherratt0Peter Libby1Hazem Dawoud2Deepak L. Bhatt3Tadeusz Malinski4R. Preston Mason5Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Durham, NH, USA; Elucida Research LLC, Beverly, MA, USADepartment of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USANanomedical Research Laboratory, Ohio University, Athens, OH, USAMount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, NY, USANanomedical Research Laboratory, Ohio University, Athens, OH, USA; Correspondence to: P.O. Box 7100, Beverly, MA 01915-0091, USA.Elucida Research LLC, Beverly, MA, USA; Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAAims: Inhalation of air pollution small particle matter (PM) is a leading cause of cardiovascular (CV) disease. Exposure to PMs causes endothelial cell (EC) dysfunction as evidenced by nitric oxide (NO) synthase uncoupling, vasoconstriction and inflammation. Eicosapentaenoic acid (EPA) has been shown to mitigate PM-induced adverse cardiac changes in patients receiving omega-3 fatty acid supplementation. We set out to determine the pro-inflammatory effects of multiple PMs (urban and fine) on pulmonary EC NO bioavailability and protein expression, and whether EPA restores EC function under these conditions. Methods and results: We pretreated pulmonary ECs with EPA and then exposed them to urban or fine air pollution PMs. LC/MS-based proteomic analysis to assess relative expression levels. Expression of adhesion molecules was measured by immunochemistry. The ratio of NO to peroxynitrite (ONOO–) release, an indication of eNOS coupling, was measured using porphyrinic nanosensors following calcium stimulation. Urban/fine PMs also modulated 9/12 and 13/36 proteins, respectively, linked to platelet and neutrophil degranulation pathways and caused > 50% (p < 0.001) decrease in the stimulated NO/ONOO– release ratio. EPA treatment altered expression of proteins involved in these inflammatory pathways, including a decrease in peroxiredoxin-5 and an increase in superoxide dismutase-1. EPA also increased expression of heme oxygenase-1 (HMOX1), a cytoprotective protein, by 2.1-fold (p = 0.024). EPA reduced elevations in sICAM-1 levels by 22% (p < 0.01) and improved the NO/ONOO– release ratio by > 35% (p < 0.05). Conclusion: These cellular changes may contribute to anti-inflammatory, cytoprotective and lipid changes associated with EPA treatment during air pollution exposure.http://www.sciencedirect.com/science/article/pii/S0753332223004171Eicosapentaenoic acidAir pollutionProteomicsPulmonary endothelial function
spellingShingle Samuel C.R. Sherratt
Peter Libby
Hazem Dawoud
Deepak L. Bhatt
Tadeusz Malinski
R. Preston Mason
Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
Biomedicine & Pharmacotherapy
Eicosapentaenoic acid
Air pollution
Proteomics
Pulmonary endothelial function
title Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
title_full Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
title_fullStr Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
title_full_unstemmed Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
title_short Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
title_sort eicosapentaenoic acid epa reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
topic Eicosapentaenoic acid
Air pollution
Proteomics
Pulmonary endothelial function
url http://www.sciencedirect.com/science/article/pii/S0753332223004171
work_keys_str_mv AT samuelcrsherratt eicosapentaenoicacidepareducespulmonaryendothelialdysfunctionandinflammationduetochangesinproteinexpressionduringexposuretoparticulatematterairpollution
AT peterlibby eicosapentaenoicacidepareducespulmonaryendothelialdysfunctionandinflammationduetochangesinproteinexpressionduringexposuretoparticulatematterairpollution
AT hazemdawoud eicosapentaenoicacidepareducespulmonaryendothelialdysfunctionandinflammationduetochangesinproteinexpressionduringexposuretoparticulatematterairpollution
AT deepaklbhatt eicosapentaenoicacidepareducespulmonaryendothelialdysfunctionandinflammationduetochangesinproteinexpressionduringexposuretoparticulatematterairpollution
AT tadeuszmalinski eicosapentaenoicacidepareducespulmonaryendothelialdysfunctionandinflammationduetochangesinproteinexpressionduringexposuretoparticulatematterairpollution
AT rprestonmason eicosapentaenoicacidepareducespulmonaryendothelialdysfunctionandinflammationduetochangesinproteinexpressionduringexposuretoparticulatematterairpollution